Valuation Theralase Technologies Inc.

Stocks

Market Closed - Toronto S.E. 14:57:22 2026-09-25 EDT			5-day change	1st Jan Change
0.1750 ^CAD	0.00%		-7.89%	+6.06%

09-15	Theralase Technologies Commences GLP Toxicology Analysis of Rutherrin	CI
08-28	Theralase Technologies Inc., Q1 2026 Earnings Call, Jun 09, 2026

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	76.6	69.28	39.98	65.66	43.71	54.33	-	-
Change	-	-9.56%	-42.29%	64.23%	-33.43%	24.31%	-	-
Enterprise Value (EV)	76.6	69.28	39.98	65.66	43.71	54.33	54.33	54.33
Change	-	-9.56%	-42.29%	64.23%	-33.43%	24.31%	0%	0%
P/E	-17x	-12.8x	-7.95x	-14.7x	-10.3x	-17.5x	8.75x	3.5x
PBR	15.1x	21.5x	17.5x	31.9x	23.5x	5.83x	3.5x	1.59x
PEG	-	-0.9x	0.7x	0.8x	0.9x	0.5x	-0x	0x
Capitalization / Revenue	98.1x	60.8x	37.4x	63.5x	53.5x	69.1x	1.6x	0.73x
EV / Revenue	0x	0x	0x	0x	0x	69.1x	1.6x	0.73x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-	-	-	-	-	-	-	-
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.022	-0.025	-0.022	-0.018	-0.016	-0.01	0.02	0.05
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	0.7806	1.139	1.07	1.033	0.8165	0.786	33.89	74.69
EBITDA	-	-	-	-	-	-	-	-
EBIT	-	-	-	-	-	-	-	-
Net income ¹	-4.411	-5.235	-4.571	-4.256	-4.121	-4.124	6.901	20.1
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	0.3750	0.3200	0.1750	0.2650	0.1650	0.1750	0.1750	0.1750
Nbr of stocks (in thousands)	204,276	216,503	228,461	247,780	264,909	310,483	-	-
Announcement Date	4/29/22	4/26/23	3/27/24	3/12/25	5/4/26	-	-	-

¹CAD in Million²CAD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
THERALASE TECHNOLOGIES INC.	-17.5x	-	-	-	38.4M
EL.EN. S.P.A.	21.65x	2.03x	10.11x	1.64%	1.43B
MODULIGHT OYJ	-10.65x	5.48x	43.84x	-	51.44M
Average	-2.17x	3.76x	26.98x	1.64%	507.39M
Weighted average by Cap.	19.57x	2.15x	11.28x	1.64%